Tanica Lyngdoh
Overview
Explore the profile of Tanica Lyngdoh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
850
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mukherjee R, Shukla V, Singh K, Lyngdoh T, Kulkarni B, Chandhiok N
J Obstet Gynaecol India
. 2025 Jan;
74(6):556-558.
PMID: 39758572
No abstract available.
2.
Mukherjee R, Gupta Bansal P, Lyngdoh T, Medhi B, Sharma K, Prashanth T, et al.
Indian J Med Res
. 2024 Oct;
159(6):547-556.
PMID: 39382466
Background & objectives Reducing maternal anaemia and enhancing feto-maternal health to achieve desired birth outcomes is a major health concern in India. Micronutrient deficiencies during pregnancy may impact fetal growth...
3.
Agarwal T, Lyngdoh T, Khadgawat R, Dudbridge F, Kinra S, Relton C, et al.
Int J Obes (Lond)
. 2024 Jul;
48(11):1552-1558.
PMID: 38971891
Background: Obesity is among the leading public health threats globally. Over the last few years, visceral adiposity index (VAI), and body adiposity index (BAI), derived from anthropometric, and biochemical measures,...
4.
Mulchandani R, Lyngdoh T, Gandotra S, Isser H, Dhamija R, Kakkar A
Front Public Health
. 2024 Mar;
12:1309089.
PMID: 38487184
The coronavirus pandemic that began in December 2019, has had an unprecedented impact on the global economy, health systems and infrastructure, in addition to being responsible for significant mortality and...
5.
Agarwal T, Lyngdoh T, Khadgawat R, Prabhakaran D, Chandak G, Walia G
Ann Hum Genet
. 2023 Sep;
87(6):255-273.
PMID: 37671428
Adiposity has gradually become a global public threat over the years with drastic increase in the attributable deaths and disability adjusted life years (DALYs). Given an increased metabolic risk among...
6.
Mulchandani R, Lyngdoh T, Nangia R, Singh S, Grover S, Thakur J
Indian J Psychiatry
. 2023 Mar;
65(1):61-67.
PMID: 36874526
Introduction: Dyslipidemia and mental illnesses are significant contributors to the global noncommunicable disease burden and studies suggest an association between them. Aim: Using data from a noncommunicable disease risk factor...
7.
Misra S, Lyngdoh T, Mulchandani R
Indian Heart J
. 2022 Aug;
74(5):341-350.
PMID: 35940234
Cardiovascular Diseases (CVD) have a high disease burden in India. Dyslipidemia, a major CVD risk factor, requires effective management. Our review describes the appropriateness of the international dyslipidemia guidelines in...
8.
Mulchandani R, Babu G, Kaur A, Singh R, Lyngdoh T
IJID Reg
. 2022 Jun;
3:54-67.
PMID: 35720145
Objectives: Since December 2019, the world has been grappling with the COVID-19 pandemic, which has caused severe loss of lives, the breakdown of health infrastructure, and disruption of the global...
9.
Singhal D, Lyngdoh T, Prabhakaran P
J Health Pollut
. 2021 Apr;
11(29):210306.
PMID: 33815904
Background: India is the fifth biggest producer of e-waste in the world, discarding 1.7 million tons in 2014. E-waste gets recycled mainly in the informal sector which means activities are...
10.
Mishra N, Salvi S, Lyngdoh T, Agrawal A
Wellcome Open Res
. 2021 Jan;
5:147.
PMID: 33381655
Low vital capacity, one of the consequences of restricted lung growth, is a strong predictor of cardiovascular mortality. Vital capacity is lower in the developing world than the developed world,...